Nippon Chemiphar Co., Ltd. (4539.T)
JPY 1512.0
(-0.13%)
JPY 1512.0
(-0.13%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 31.08 Billion JPY | 3.48% |
| 2022 | 30.03 Billion JPY | -2.95% |
| 2021 | 30.95 Billion JPY | 6.32% |
| 2020 | 29.11 Billion JPY | 2.24% |
| 2019 | 28.47 Billion JPY | -2.04% |
| 2018 | 29.06 Billion JPY | -0.89% |
| 2017 | 29.32 Billion JPY | -1.08% |
| 2016 | 29.64 Billion JPY | 7.4% |
| 2015 | 27.6 Billion JPY | 6.98% |
| 2014 | 25.8 Billion JPY | -3.02% |
| 2013 | 26.6 Billion JPY | 15.27% |
| 2012 | 23.08 Billion JPY | -2.04% |
| 2011 | 23.56 Billion JPY | 7.96% |
| 2010 | 21.82 Billion JPY | 0.4% |
| 2009 | 21.73 Billion JPY | 21.77% |
| 2008 | 17.84 Billion JPY | 20.43% |
| 2007 | 14.82 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 32.64 Billion JPY | 5.03% |
| 2024 Q2 | 33.46 Billion JPY | 2.52% |
| 2023 FY | 31.08 Billion JPY | 3.48% |
| 2023 Q2 | 32.32 Billion JPY | -4.04% |
| 2023 Q4 | 31.08 Billion JPY | -3.45% |
| 2023 Q1 | 33.68 Billion JPY | 12.14% |
| 2023 Q3 | 32.19 Billion JPY | -0.4% |
| 2022 Q2 | 31.68 Billion JPY | -3.38% |
| 2022 Q1 | 32.79 Billion JPY | 5.95% |
| 2022 Q3 | 30.86 Billion JPY | -2.58% |
| 2022 FY | 30.03 Billion JPY | -2.95% |
| 2022 Q4 | 30.03 Billion JPY | -2.68% |
| 2021 Q3 | 31.8 Billion JPY | 4.88% |
| 2021 FY | 30.95 Billion JPY | 6.32% |
| 2021 Q1 | 30.22 Billion JPY | 3.81% |
| 2021 Q2 | 30.32 Billion JPY | 0.35% |
| 2021 Q4 | 30.95 Billion JPY | -2.69% |
| 2020 Q2 | 29.84 Billion JPY | -1.76% |
| 2020 Q1 | 30.38 Billion JPY | 6.71% |
| 2020 Q3 | 30.57 Billion JPY | 2.43% |
| 2020 FY | 29.11 Billion JPY | 2.24% |
| 2020 Q4 | 29.11 Billion JPY | -4.78% |
| 2019 Q1 | 30.58 Billion JPY | 5.23% |
| 2019 Q2 | 29.56 Billion JPY | -3.34% |
| 2019 FY | 28.47 Billion JPY | -2.04% |
| 2019 Q4 | 28.47 Billion JPY | -4.15% |
| 2019 Q3 | 29.7 Billion JPY | 0.47% |
| 2018 Q2 | 29.56 Billion JPY | -2.69% |
| 2018 Q3 | 29.86 Billion JPY | 1.03% |
| 2018 FY | 29.06 Billion JPY | -0.89% |
| 2018 Q4 | 29.06 Billion JPY | -2.68% |
| 2018 Q1 | 30.37 Billion JPY | 3.58% |
| 2017 Q1 | 31.02 Billion JPY | 4.65% |
| 2017 Q4 | 29.32 Billion JPY | -2.12% |
| 2017 Q3 | 29.96 Billion JPY | 2.63% |
| 2017 Q2 | 29.19 Billion JPY | -5.91% |
| 2017 FY | 29.32 Billion JPY | -1.08% |
| 2016 Q1 | 28.24 Billion JPY | 2.33% |
| 2016 Q4 | 29.64 Billion JPY | 4.02% |
| 2016 Q3 | 28.5 Billion JPY | 5.08% |
| 2016 Q2 | 27.12 Billion JPY | -3.98% |
| 2016 FY | 29.64 Billion JPY | 7.4% |
| 2015 Q3 | 27.13 Billion JPY | 3.71% |
| 2015 FY | 27.6 Billion JPY | 6.98% |
| 2015 Q4 | 27.6 Billion JPY | 1.71% |
| 2015 Q2 | 26.16 Billion JPY | -4.53% |
| 2015 Q1 | 27.41 Billion JPY | 6.23% |
| 2014 Q2 | 27.33 Billion JPY | -7.46% |
| 2014 Q4 | 25.8 Billion JPY | -5.39% |
| 2014 FY | 25.8 Billion JPY | -3.02% |
| 2014 Q3 | 27.27 Billion JPY | -0.23% |
| 2014 Q1 | 29.53 Billion JPY | 11.01% |
| 2013 Q2 | 26.02 Billion JPY | 1.8% |
| 2013 Q3 | 27.07 Billion JPY | 4.0% |
| 2013 Q4 | 26.6 Billion JPY | -1.72% |
| 2013 FY | 26.6 Billion JPY | 15.27% |
| 2013 Q1 | 25.56 Billion JPY | 10.78% |
| 2012 Q1 | 26.94 Billion JPY | 14.36% |
| 2012 Q3 | 24.63 Billion JPY | -6.66% |
| 2012 Q2 | 26.38 Billion JPY | -2.07% |
| 2012 FY | 23.08 Billion JPY | -2.04% |
| 2012 Q4 | 23.08 Billion JPY | -6.29% |
| 2011 Q1 | 24.72 Billion JPY | 13.3% |
| 2011 Q4 | 23.56 Billion JPY | -0.61% |
| 2011 FY | 23.56 Billion JPY | 7.96% |
| 2011 Q3 | 23.7 Billion JPY | -0.21% |
| 2011 Q2 | 23.75 Billion JPY | -3.93% |
| 2010 Q3 | 22.26 Billion JPY | -0.38% |
| 2010 Q4 | 21.82 Billion JPY | -1.98% |
| 2010 FY | 21.82 Billion JPY | 0.4% |
| 2010 Q1 | 22.93 Billion JPY | 5.54% |
| 2010 Q2 | 22.34 Billion JPY | -2.58% |
| 2009 Q2 | 20.24 Billion JPY | 0.0% |
| 2009 Q4 | 21.73 Billion JPY | -5.04% |
| 2009 Q3 | 22.88 Billion JPY | 13.07% |
| 2009 FY | 21.73 Billion JPY | 21.77% |
| 2008 Q3 | 17.31 Billion JPY | 0.0% |
| 2008 Q4 | 17.84 Billion JPY | 3.08% |
| 2008 FY | 17.84 Billion JPY | 20.43% |
| 2007 FY | 14.82 Billion JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 24.98 Billion JPY | -24.396% |
| Takeda Pharmaceutical Company Limited | 7834.78 Billion JPY | 99.603% |
| Sumitomo Pharma Co., Ltd. | 751.37 Billion JPY | 95.863% |
| Shionogi & Co., Ltd. | 164.35 Billion JPY | 81.087% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.39 Billion JPY | -815.587% |
| Nippon Shinyaku Co., Ltd. | 42.86 Billion JPY | 27.489% |
| Kaken Pharmaceutical Co., Ltd. | 27.86 Billion JPY | -11.548% |
| Eisai Co., Ltd. | 494.82 Billion JPY | 93.718% |
| Morishita Jintan Co., Ltd. | 5.04 Billion JPY | -516.746% |
| Hisamitsu Pharmaceutical Co., Inc. | 61.69 Billion JPY | 49.616% |
| Mochida Pharmaceutical Co., Ltd. | 30.83 Billion JPY | -0.817% |
| Fuso Pharmaceutical Industries,Ltd. | 39.79 Billion JPY | 21.888% |
| Tsumura & Co. | 132.88 Billion JPY | 76.609% |
| Kissei Pharmaceutical Co., Ltd. | 39.79 Billion JPY | 21.882% |
| Torii Pharmaceutical Co., Ltd. | 13.29 Billion JPY | -133.767% |
| Towa Pharmaceutical Co., Ltd. | 274.75 Billion JPY | 88.687% |
| Fuji Pharma Co., Ltd. | 44.15 Billion JPY | 29.607% |
| Zeria Pharmaceutical Co., Ltd. | 70.7 Billion JPY | 56.037% |
| KYORIN Holdings, Inc. | 46.89 Billion JPY | 33.713% |
| Taiko Pharmaceutical Co.,Ltd. | 7 Billion JPY | -343.867% |
| Daito Pharmaceutical Co.,Ltd. | 25.43 Billion JPY | -22.19% |
| SymBio Pharmaceuticals Limited | 8.14 Billion JPY | -281.767% |
| MedRx Co., Ltd | 129 Million JPY | -23996.124% |
| Mizuho Medy Co.,Ltd. | 3.27 Billion JPY | -849.845% |
| Solasia Pharma K.K. | 673 Million JPY | -4518.722% |
| Modalis Therapeutics Corporation | 645.5 Million JPY | -4715.469% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 31.38 Billion JPY | 0.946% |
| Sawai Group Holdings Co., Ltd. | 163.99 Billion JPY | 81.046% |
| Cyfuse Biomedical K.K. | 1.01 Billion JPY | -2973.546% |
| Toho Holdings Co., Ltd. | 523.98 Billion JPY | 94.068% |
| Koa Shoji Holdings Co.,Ltd. | 6.95 Billion JPY | -347.101% |